Spanish drug spending down by a fifth
This article was originally published in Scrip
Executive Summary
Spanish spending on pharmaceuticals is down yet again. Figures from the Spanish health ministry reveal a 20% drop in spending in August compared with the same month last year. More cost saving measures applicable from July, including increased patient co-payments and the removal of products from the reimbursement list, contributed significantly to the decline, says the ministry.